SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Madhur D Shastri, Gregory M Peterson, Niall Stewart, Sukhwinder Singh Sohal, Rahul P Patel, Non-anticoagulant derivatives of heparin for the management of asthma: distant dream or close reality?, Expert Opinion on Investigational Drugs, 2014, 23, 3, 357

    CrossRef

  2. 2
    O. J. Price, L. Ansley, A. Menzies-Gow, P. Cullinan, J. H. Hull, Airway dysfunction in elite athletes – an occupational lung disease?, Allergy, 2013, 68, 11
  3. 3
    Stacey L. Tannheimer, Eric A. Sorensen, Aaron C. Haran, Christopher N. Mansfield, Clifford D. Wright, Michael Salmon, Additive anti-inflammatory effects of beta 2 adrenoceptor agonists or glucocorticosteroid with roflumilast in human peripheral blood mononuclear cells, Pulmonary Pharmacology & Therapeutics, 2012, 25, 2, 178

    CrossRef

  4. 4
    G Walter Canonica, Christopher Brightling, Section 3. A Discussion of Flexible Dosing and Patient-Centered Therapy, World Allergy Organization Journal, 2010, 3, 2, 31

    CrossRef

  5. 5
    D. Robin Taylor, The β-Agonist Saga and Its Clinical Relevance: On and On It Goes, American Journal of Respiratory and Critical Care Medicine, 2009, 179, 11, 976

    CrossRef

  6. 6
    D Robin Taylor, β-Adrenergic receptor polymorphisms: relationship to the β-agonist controversy and clinical implications, Expert Opinion on Pharmacotherapy, 2007, 8, 18, 3195

    CrossRef

  7. 7
    Bill T. Ameredes, William J. Calhoun, (R)-Albuterol for Asthma: Pro [a.k.a. (S)-Albuterol for Asthma: Con], American Journal of Respiratory and Critical Care Medicine, 2006, 174, 9, 965

    CrossRef

  8. 8
    Bill T. Ameredes, William J. Calhoun, Rebuttal by Drs. Ameredes and Calhoun, American Journal of Respiratory and Critical Care Medicine, 2006, 174, 9, 972

    CrossRef

  9. 9
    Bill T. AMEREDES, Adverse effects of short-acting beta-agonists: potential impact when anti-inflammatory therapy is inadequate: Comment, Respirology, 2004, 9, 4